Plate Nº 38 · recorded October 10, 2026
Health & Medicine ResearchReported finding
Robotic Joint Replacement Does Not Lower Early Repeat Surgery Risk
Two BMJ studies of over 1 million NHS joint replacements found robotic-assisted hip and knee surgery does not reduce early repeat-surgery risk overall, despite costing £1,000–£2,500 more per procedure.
By James Calloway3 min read612 words
In brief
- Over 1 million joint replacements analyzed using National Joint Registry data collected between 2018 and 2024
- Two studies published in The BMJ by Queen Mary University of London, the University of Oxford, and the University of Bristol
- Robotic systems cost around £1 million to install and add £1,000–£2,500 per procedure
- NHS plans a sevenfold increase in robotic joint-replacement procedures by 2035
- Robotic hip replacement linked to fewer malpositioning-related revisions, but no overall reduction in repeat surgery

Two studies analyzing more than 1 million joint replacements found that robotic-assisted hip and knee surgery does not reduce the overall early risk of needing a repeat operation compared with conventional surgery.
The research, published in The BMJ, drew on National Joint Registry records collected between 2018 and 2024. It represents the largest real-world evaluation to date of whether the greater technical precision offered by robotic assistance actually helps patients.
What did the studies find?
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford, Queen Mary University of London and the University of Bristol ran parallel analyses of hip and knee replacements performed across the NHS.
Key findings:
- Hip study: no overall reduction in repeat surgery or mortality with robotic assistance. Robotic hip replacement did link to a lower risk of revision surgery specifically caused by implant malpositioning.
- Knee study: no difference in repeat surgery risk between robotic and conventional approaches.
- Both studies measured early outcomes only.
Why doesn't more precise implant placement reduce repeat surgery?
In robotic-assisted joint replacement, the surgeon stays in control of the operation. Computer and robotic tools help plan and guide implant placement, with the goal of positioning the joint more accurately than unassisted surgery allows.
Better positioning should, in theory, reduce both early and long-term failure. Yet the new data suggest that technical precision does not necessarily yield better overall early results.
Implant malpositioning means the new joint sits at the wrong angle or depth. A poorly placed implant can wear out faster, loosen, or cause pain that sends patients back to the operating table. The hip study hints that robotic tools do what their makers promise on this narrow front. They do not appear to fix the broader set of reasons a joint replacement fails.
For hips, the specific gain seen with robotic surgery — fewer revisions caused by malpositioning — was offset elsewhere, leaving the total repeat-surgery rate unchanged.
How much does robotic surgery cost?
The technology carries substantial upfront expense. Robotic systems cost around £1 million to introduce into a hospital. Each procedure adds between £1,000 and £2,500 to the bill.
These figures land at a sensitive moment for the NHS. The health service plans a major expansion of robotic surgery, aiming to increase the number of procedures sevenfold by 2035.
How did the researchers reach these conclusions?
The teams used a method called target trial emulation. This statistical approach balances patients according to known differences in their characteristics, making comparisons between large patient groups more closely resemble those of a randomized clinical trial.
Hasan Mohammad, an academic clinical lecturer in trauma and orthopedics at Queen Mary and lead author of the study, said: "This study, which uses novel methodology and represents the largest real-world analysis of its kind worldwide, provides important independent evidence for patients, surgeons and policymakers at a time when robotic hip and knee replacement surgery is being adopted rapidly. New technology should deliver meaningful benefit for patients and represent good value for a publicly funded health service."
What are the limitations?
The studies tracked only early outcomes. Longer follow-up may reveal whether differences in implant survival emerge over time.
Registry data, while comprehensive, cannot capture every clinical detail that matters. Surgeon experience with robotic systems also varied across hospitals, and outcomes may improve as operators become more practiced — a possibility the early data cannot yet rule out.
The knee study, titled "Are robotic knee replacements superior? An early national comparison of robotic versus conventional knee replacements for arthritis using registry data," appeared in The BMJ in 2026 (DOI: 10.1136/bmj-2026-100691).
via Medical Xpress (Source)
More from James Calloway
Show full bio
Staff writer covering marketplaces and e-commerce at SciBeat.
205 articles
Nearby plates
- Eli Lilly's Next-Generation Obesity Drug Cuts Weight and Eases Knee Pain in Phase 3 Trial
- Wrist Sensor Beats Clinicians at Tracking Stroke Recovery
- Epilepsy Drug Lacosamide May Reverse Osteoarthritis Cartilage Damage
- Blocking One Aging Protein Regrew Knee Cartilage in Mice
- High blood pressure accelerates osteoarthritis via hormone pathway